Wim Goemaere

Biography

  Mr. Wim Goemaere, MAE has been Chief Financial Officer of deVGen NV since January 7, 2008. Mr. Goemaere served as the Chief Financial Officer at Bone Therapeutics SA until September 1, 2017. Mr. Goemaere served as an Executive Managing Director at Bone Therapeutics SA until March 11, 2017. Mr. Goemaere has 20 years of industry experience in corporate finance and financial management. Mr. Goemaere is an experienced senior financial executive with over 25 years international business experience, the majority of which he spent within the biotechnology field. Previously, he served as Chief Financial Officer at VIB (the Flanders Institute for Biotechnology) in Ghent. At VIB, his responsibilities included finance and control, tax management, corporate information technology and corporate legal issues. He was instrumental in building and shaping VIB together with the other members of the management team. He originally joined VIB in 1995. He started his career with BP Chemicals in Antwerp in 1987 as analyst and he held various other positions at BP until he was appointed controller at BP Belgium NV in 1993 until 1995 when he joined VIB. In 2008, he moved to Devgen, a Belgium-based multinational agro-biotech company listed on NYSE Euronext Brussels, where he held the position of Chief Financial Officer for five years. Mr. Goemaere played a key role in the Institute's development from start-up to one of the world's leading research bodies in life sciences. Mr. Goemaere was instrumental in ensuring endorsement of Devgen in the financial markets and in the take-over of Devgen by Syngenta for €403 million. Furthermore, he played an important role into the company's business expansion in Asia. He has been Non-Executive Director at Bone Therapeutics SA since 2013 and served as its Executive Director from 2013 to September 1, 2017. Mr. Goemaere holds a Master Degree and Degree in Applied Economics from The University of Leuven in 1987.

Research Interest

  Applied Economics